SeaStar Medical Holding (ICU) Enterprise Value (2020 - 2026)
SeaStar Medical Holding's (ICU) quarterly Enterprise Value came in at -$9.3 million in Q1 2026, down 75.6% YoY from -$38.1 million in Q1 2025, and up 32.43% on a QoQ basis from -$13.8 million in Q3 2025.
SeaStar Medical Holding (ICU) Enterprise Value (2020 - 2026) Analysis & Trends
SeaStar Medical Holding (ICU) has 7 years of Enterprise Value data on file, last reported at -$9.3 million in Q1 2026.
- Quarterly Enterprise Value fell 75.6% year-over-year to -$9.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$9.3 million (down 75.6% YoY) and the FY2024 annual result came in at -$1.8 million, down 933.52% from the prior year.
- Enterprise Value rose to -$9.3 million in Q1 2026, from -$13.8 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$13000.0 in Q2 2023 to a low of -$13.8 million in Q3 2025.
- A 5-year average of -$2.9 million and a median of -$952000.0 in 2023 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2023 — Enterprise Value jumped 97.88% — and 2024, when it sank 8969.23%.
- Tracing ICU's Enterprise Value over 5 years: stood at -$47000.0 in 2022, then sank by 274.47% to -$176000.0 in 2023, then tumbled by 933.52% to -$1.8 million in 2024, then sank by 656.62% to -$13.8 million in 2025, then soared by 32.43% to -$9.3 million in 2026.
- The last three Enterprise Value figures came in at -$9.3 million (Q1 2026), -$13.8 million (Q3 2025), and -$6.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 2.12 Bn |
| 10 | SeaStar Medical Holding | 14.07 Mn | 7.07 Mn | 561,000.00 | -7.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.00 Mn |
| Mar 31, 2026 | -9.30 Mn |
| Sep 30, 2025 | -13.76 Mn |
| Jun 30, 2025 | -6.30 Mn |
| Mar 31, 2025 | -5.30 Mn |
| Dec 31, 2024 | -1.82 Mn |
| Sep 30, 2024 | -2.08 Mn |
| Jun 30, 2024 | -1.18 Mn |
| Mar 31, 2024 | -5.02 Mn |
| Dec 31, 2023 | -176,000.00 |
| Sep 30, 2023 | -73,000.00 |
| Jun 30, 2023 | -13,000.00 |
| Mar 31, 2023 | -725,000.00 |
| Dec 31, 2022 | -47,000.00 |
| Sep 30, 2022 | -49,000.00 |
| Jun 30, 2022 | -613,000.00 |
| Mar 31, 2022 | -207,000.00 |
| Dec 31, 2021 | -510,000.00 |
| Sep 30, 2021 | -165,840.00 |
| Jun 30, 2021 | -339,724.00 |